U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
TOMUZOTUXIMAB
INN  
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C225 .KAPPA.-CHAIN, DIMER, GLYCOFORM
Preferred Name English
Tomuzotuximab [WHO-DD]
Common Name English
tomuzotuximab [INN]
Common Name English
Code System Code Type Description
FDA UNII
5P637IXG16
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
CAS
1646321-00-7
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
SMS_ID
300000021832
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
NCI_THESAURUS
C152692
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
DRUG BANK
DB15178
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
INN
10334
Created by admin on Tue Apr 01 20:19:24 GMT 2025 , Edited by admin on Tue Apr 01 20:19:24 GMT 2025
PRIMARY
ACTIVE MOIETY
TOMUZOTUXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966